Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

6
Number of overlapping holdings
20.0%
% of MEDX's 30 holdings also in SYNB
18.2%
% of SYNB's 35 holdings also in MEDX
Overlap by Weight
Sector Drift (MEDX minus SYNB)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in MEDX |
Weight in SYNB |
Overlap | |
---|---|---|---|---|
ABBVIE INC | 9.4% | 5.5% | 5.5% | |
ASTRAZENECA PLC-SPONS ADR | 5.8% | 4.2% | 4.2% | |
ELI LILLY & CO | 17.1% | 4.0% | 4.0% | |
REGENERON PHARMACEUTICALS | 2.8% | 2.6% | 2.6% | |
ALNYLAM PHARMACEUTICALS INC | 4.8% | 1.0% | 1.0% |
Position Highlights (Non-Overlapping Exposures)
MEDX Overweight Relative to SYNB
ELI LILLY & CO | 13.1% | |
NOVARTIS AG-ADR | 7.2% | |
AMGEN INC | 6.7% | |
BRISTOL-MYERS SQUIBB CO | 6.3% | |
JOHNSON & JOHNSON | 5.4% | |
ALKERMES PLC | 4.3% | |
PFIZER INC | 4.0% | |
ABBVIE INC | 3.9% | |
ALNYLAM PHARMACEUTICALS INC | 3.8% | |
MERCK & CO. INC. | 3.7% |
MEDX Underweight Relative to SYNB
THERMO FISHER SCIENTIFIC INC | -6.7% | |
DANAHER CORP | -5.6% | |
CORTEVA INC | -4.9% | |
NOVOZYMES A/S-UNSPONS ADR | -4.6% | |
BIO-RAD LABORATORIES-CL A | -4.6% | |
ASCENDIS PHARMA A/S | -4.0% | |
ALPHABET INC. CLASS A | -3.9% | |
NVIDIA CORP | -3.5% | |
DUPONT DE NEMOURS INC | -3.5% | |
ZOETIS INC | -2.8% |